Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients

Landiolol is an ultra-short-acting β1-selective antagonist developed in Japan that was recently approved for the treatment of tachycardia in intensive care units (ICUs). This study investigated the protective effects of landiolol against the cardiovascular responses during bronchoscopic endotracheal...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of intensive care 2014-01, Vol.2 (1), p.6-6, Article 6
Hauptverfasser:	Tochikubo, Junpei, Adachi, Yushi U, Ejima, Tadashi, Numaguchi, Atsushi, Matsuda, Naoyuki, Sato, Shigehito, Shiiya, Norihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Care and treatment Equipment and supplies Letter to the Editor Medical colleges Medical research Medicine, Experimental Methods Tachycardia Venous pressure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!